http://www.verastem.com
Verastem, Inc. Company Intro
Verastem Oncology (NASDAQ: VSTM) is a biopharmaceutical company focused on development of medicines to improve the lives of patients diagnosed with cancer.
Industry
Healthcare
Verastem, Inc. Headquaters
117 Kendrick Street
Needham,02494
United States
Verastem, Inc. Share price
29 Jul 2021 01:27 GMT
$3.2600
-0.01 (-0.31 %)
Verastem, Inc. Market cap
$582.805 M
WMC RANKING
2021
Verastem, Inc. # 70
BiotechnologyLatest Verastem, Inc. News
27 Jul 2021
Verastem Inc (VSTM) Stock Has Fallen -12.77% This Week ...
Verastem Inc (VSTM) stock has risen 126.06% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.
27 Jul 2021
Cordant, Inc. Buys iShares Core MSCI International ...
Cordant, Inc. Buys iShares Core MSCI International Developed Markets , Nano X ... Cordant, Inc. sold out a holding in Verastem Inc. The sale prices were ...
28 Jul 2021
Shareholders Are Thrilled That The Verastem (NASDAQ ...
Verastem, Inc. (NASDAQ:VSTM) shareholders have seen the share price descend ... Verastem isn't currently profitable, so most analysts would look to revenue ...
WMC Market Score
WMC Market to Revenue Score
Verastem, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Verastem, Inc. | USD | $84,466 | $88,717 | $-44,767 | $5,828M | 70 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $624,780B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $523,530B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $403,360B | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $171,560B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Verastem, Inc. Social Followers vs Top 4 Industry Competitors
Verastem, Inc. Post vs Top 4 Industry Competitors
Verastem, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Verastem, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Verastem, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Verastem, Inc. | 0.92 | 1.23 | 0.01 | 0 | 0 | 0 | 0.48 |
| Regeneron Pharmaceuticals, Inc. | 100 | 24.33 | 16.06 | 100 | 0 | 0 | 53.97 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.02 | 8.75 | 86 | 0 | 0 | 49.82 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 60 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 4.95 | 0.02 | 2 | 0 | 0 | 2.85 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
